Clinical Use of Phosphodiesterase-5 Inhibitors in Chronic Heart Failure

被引：38

作者：

Guazzi, Marco ^{[1
]}

机构：

[1] Univ Milan, Heart Failure Unit, Cardiopulm Lab, San Paolo Hosp,Dept Med & Surg, I-20142 Milan, Italy

来源：

CIRCULATION-HEART FAILURE | 2008年 / 1卷 / 04期

关键词：

heart failure; pharmacology;

D O I：

10.1161/CIRCHEARTFAILURE.108.802116

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：272 / 280

页数：9

共 71 条

[61] Impaired pulmonary diffusion during exercise in patients with chronic heart failure [J].

Smith, AA ;

Cowburn, PJ ;

Parker, ME ;

Denvir, M ;

Puri, S ;

Patel, KR ;

Cleland, JGF .

CIRCULATION, 1999, 100 (13) :1406-1410

[62] Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5) [J].

Stacey, P ;

Rulten, S ;

Dapling, A ;

Phillips, SC .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (02) :249-254

[63]

SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077

[64] cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism [J].

Takimoto, E ;

Champion, HC ;

Belardi, D ;

Moslehi, J ;

Mongillo, M ;

Mergia, E ;

Montrose, DC ;

Isoda, T ;

Aufiero, K ;

Zaccolo, M ;

Dostmann, WR ;

Smith, CJ ;

Kass, DA .

CIRCULATION RESEARCH, 2005, 96 (01) :100-109

[65] Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy [J].

Takimoto, E ;

Champion, HC ;

Li, MX ;

Belardi, D ;

Ren, SX ;

Rodriguez, ER ;

Bedja, D ;

Gabrielson, KL ;

Wang, YB ;

Kass, DA .

NATURE MEDICINE, 2005, 11 (02) :214-222

[66] Compartmentalization of cardiac β-adrenergic inotropy modulation by phosphodiesterase type 5 [J].

Takimoto, Eiki ;

Belardi, Diego ;

Tocchetti, Carlo G. ;

Vahebi, Susan ;

Cormaci, Gianfrancesco ;

Ketner, Elizabeth A. ;

Moens, An L. ;

Champion, Hunter C. ;

Kass, David A. .

CIRCULATION, 2007, 115 (16) :2159-2167

[67] Combination of isosorbide dinitrate and hydralazine in blacks with heart failure [J].

Taylor, AL ;

Ziesche, S ;

Yancy, C ;

Carson, P ;

D'Agostino, R ;

Ferdinand, K ;

Taylor, M ;

Adams, K ;

Sabolinski, M ;

Worcel, M ;

Cohn, JN .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (20) :2049-2057

[68] Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta [J].

Teixeira, CE ;

Priviero, FBM ;

Webb, RC .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (02) :654-661

[69] Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man [J].

Walker, DK ;

Ackland, MJ ;

James, GC ;

Muirhead, GJ ;

Rance, DJ ;

Wastall, P ;

Wright, PA .

XENOBIOTICA, 1999, 29 (03) :297-310

[70] Regulation of intracellular Ca2+ release in corpus cavernosum smooth muscle:: synergism between nitric oxide and cGMP [J].

Williams, BA ;

Liu, CQ ;

DeYoung, L ;

Brock, GB ;

Sims, SM .

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2005, 288 (03) :C650-C658

← 1 2 3 4 5 6 7 8 →